The next age of immunotherapy: optimisation, stratification and therapeutic synergies

Open Access
Publisher Website
Google Scholar
Abstract
Cancer immunotherapy has entered a phase of broad application in the treatment of patients with haematologic and solid tumours. From first steps to standard of care, immunotherapy has established its utility and applicability across different cancer types. Now it must demonstrate its higher potential in more personalised and stratified approaches.